Barclays Reinstates Teva Pharma (TEVA) at Equalweight

November 14, 2016 7:48 AM EST
Get Alerts TEVA Hot Sheet
Price: $36.53 -0.11%

Rating Summary:
    21 Buy, 18 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade TEVA Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Barclays reinstated coverage on Teva Pharma (NYSE: TEVA) with an Equalweight rating and a price target of $46.00.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $40.65 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities


Add Your Comment